Sonnet BioTherapeutics Plans Shift to Hyperliquid Strategies, Potentially Becoming Major U.S. Holder of HYPE Token

Jul 14 2025 crypto


Sonnet BioTherapeutics is strategically pivoting from biotech to crypto by merging with Rorschach to form Hyperliquid Strategies, targeting significant holdings in the HYPE token. This $888 million entity aims to



We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.